BACK

When it comes to Alzheimer's, dementia, and other neuropsychiatric disorders including depression, early detection is key. Unfortunately, since most detection requires monitoring from healthcare professionals, that process can often be complicated which causes it to be delayed.

iMediSync, a biotech startup that is developing an AI-driven early detection and therapeutic platform for brain health, is showcasing at CES 2021 an EEG (electroencephalogram) brain mapping and LED-therapeutic device called iSyncWave.

iSyncWave is gel-free, portable, and works with a mobile application that connects to iMediSync’s cloud platform allowing patients to immediately share their EEG data with health care and mental healthcare professionals. This allows monitoring and diagnosis to be made from the comfort of the patient's home rather than forcing the patient to visit a healthcare facility.